Leading the way in oncology diagnostics, NeoGenomics offers 500+ advanced tests across all major modalities, for precise and personalized cancer care.

Dec 3, 2025 · NeoGenomics will continue to offer testing solutions for AML patients, including IDH1 and IDH2 testing, and support oncologists in making informed treatment decisions. To …

Quickly find the right diagnostic test with NeoGenomics’ easy-to-navigate catalog, designed to streamline the selection process for cancer care providers.

3 days ago · NeoGenomics is committed to innovation in cancer diagnostics, providing comprehensive testing solutions to advance precision medicine for your patients.

NeoGenomics provides turn-key services that identify appropriate lab methodologies for internalization, assist in the unification of reference lab solutions, and support the optimization …

NeoGenomics provides turn-key services that identify appropriate pathology lab methodologies for internalization, assist in the unification of reference lab solutions, and support the optimization …

NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help …

At NeoGenomics, our priority is patient health. Every day, we are improving access to diagnostic tools that can advance patient outcomes through transformative oncology testing.

Connect with NeoGenomics (phone, fax, or email) for inquiries and support, ensuring seamless communication about your oncology diagnostic needs.

NeoGenomics offers extensive support resources, providing healthcare professionals with the tools and information needed for optimal patient care.